Xenotransplantation is the fusion energy of medicine. As the well-worn joke goes, it is the future—and always will be. But ...

CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $62.56, moving -2.51% from the previous trading session. Elsewhere, the Dow saw a downswing of 0.16%, while the tech-heavy Nasdaq ...

In many cells of the human body, hair-like protrusions known as cilia act as antennae, allowing cells to receive signals from ...

As flu season approaches and public health officials roll out their annual push for vaccination, Allen Institute scientists ...

A research team has successfully engineered a japonica rice variety using CRISPR/Cas9 to simultaneously optimize plant ...

Ozempic, MRI machines and flat screen televisions all emerged out of fundamental research decades earlier — the very types of ...

Martin Kampmann’s work, supported by the National Institutes of Science (NIH), maps cellular “decision points” that determine ...

We are now in the second great wave of the genetic revolution, not defined by reading the human code of life, but by rewriting it.

Intellia paused both trials after receiving a report of grade 4 liver enzymes and increased total bilirubin in a patient in ...

Researchers have identified molecular mechanisms behind age-related memory decline — and shown they can be reversed.

St. Jude researchers advance CASTs, enhancing precision and activity for next-generation genome-editing therapies.